Latest News
View All →-
Sep 07, 2026
YolTech Presented Proof-of-Concept Data from Clinical Trial of YOLT-202 in PiZZ Alpha-1 Antitrypsin Deficiency (AATD) Patients at European Respiratory Society Congress 2026
-
Sep 05, 2026
YolTech to Present Late-Breaking Proof-of-Concept Clinical Data from YOLT-202 Clinical Trial in PiZZ Alpha-1 Antitrypsin Deficiency (AATD) Patients at European Respiratory Society Congress 2026
-
Aug 27, 2026
YolTech to Present Positive Data from Clinical Trial of YOLT-201 in ATTR-CM Patients at European Society of Cardiology Congress 2026
-
Jul 20, 2026
YolTech Therapeutics Appoints Jessie Yeung as Chief Financial Officer
-
Jun 30, 2026
YolTech at Hope for Rare Science Conference 2026
Contact
-
Investor Contact
-
Company Contact
